CLINICAL_TRIALS trial_result · 2024-07-31

Clinical Trial Update: Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases [NA]

A completed feasibility study by Varian evaluating FLASH radiotherapy for symptomatic bone metastases; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Bone Metastasis | NA | Status: COMPLETED | Results posted: 2024-07-31